Wounded and weaponless, he has stumbled upon a group of survivors who may be his last hope. But a tragedy in the group causes a deep rift and forces him into action. Read more...
- Retail Price:
20% off for Members: Get the Club Price
Customers Also Bought
Wounded and weaponless, he has stumbled upon a group of survivors who may be his last hope. But a tragedy in the group causes a deep rift and forces him into action.
And in the chaos of a world overrun by infected, Lee is pursued by a new threat: someone who will stop at nothing to keep him from his sworn duty.
This is the second novel D.J. Molles's bestselling series:
Book 1: "The Remaining"
Book 2: "The Remaining: Aftermath"
Book 3: "The Remaining: Refugees"
Book 4: "The Remaining: Fractured""
Novella 1: The Remaining: TrustNovella 2: The Remaining: Faith"
- ISBN-13: 9780316404174
- ISBN-10: 0316404179
- Publisher: Orbit
- Publish Date: June 2014
- Page Count: 448
Series: Remaining #2
Publishers Weekly® Reviews
- Reviewed in: Publishers Weekly, page .
- Review Date: 2014-04-28
- Reviewer: Staff
Molles (The Remaining) continues the vigorously authored, formidable saga of army captain Lee Harden’s mission to restore civilization while survivors fight off hordes of savage zombie-like infected. Injured and overwhelmed, Harden barely managed to survive the first novel, but having been rescued, he is now on surer footing. Molles continues to supply Harden with enough depth to keep him from becoming a stock action character, but escalates both the intense combat and grim horror, as well as substantially expanding the cast of characters. Harden manages to get to his first bunker of cached supplies, a victory that is soon overshadowed by the increasingly disturbing tactical skills of the so-called zombies, the megalomaniacal leader of a band of predatory raiders, and some truly surprising betrayals. A cramped and claustrophobic hospital provides both a forbidding backdrop for a harrowing showdown, and an opportunity to stretch the story further into what should be an eagerly awaited sequel. (June)